Indigestion follows €433m Arkema sale

Groupe Bruxelles Lambert sold its entire 10.01% stake in French chemicals firm Arkema on Wednesday following a strong run in the stock price over the last six months and since the company reported results last week. It traded weakly following the tightly-priced deal, but bankers and analysts away from the deal remain bullish on the stock and expect the indigestion to clear soon.

  • 14 Mar 2012
The seller, advised by Rothschild & Cie, mandated Bank of America Merrill Lynch and HSBC following an auction and they launched an accelerated bookbuild for the up-to 6.2m share sale at around 6.45pm GMT. Price guidance was given at €69.90 to market, a discount of up to 3.73% ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 159,441.15 688 8.06%
2 Citi 156,412.44 629 7.91%
3 Bank of America Merrill Lynch 128,902.57 511 6.52%
4 Barclays 125,463.27 484 6.34%
5 HSBC 102,014.24 510 5.16%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Bank of America Merrill Lynch 12,900.23 34 6.66%
2 BNP Paribas 12,334.48 61 6.37%
3 UniCredit 11,196.47 58 5.78%
4 Citi 9,580.75 37 4.95%
5 Deutsche Bank 8,953.95 35 4.62%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Morgan Stanley 5,254.13 23 10.50%
2 JPMorgan 4,766.39 27 9.53%
3 Goldman Sachs 4,259.98 19 8.51%
4 Citi 3,649.88 23 7.29%
5 UBS 3,602.23 16 7.20%